A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
CONCLUSIONS: ML modeling effectively subclassified patients with BCLC-C HCC, potentially aiding treatment allocation. Our study underscores the potential utilization of ML modeling in terms of prognostication and treatment allocation in patients with BCLC-C HCC.PMID:38639918 | DOI:10.1158/1078-0432.CCR-23-3978
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Ji Won Han Soon Kyu Lee Jung Hyun Kwon Soon Woo Nam Hyun Yang Si Hyun Bae Ji Hoon Kim Heechul Nam Chang Wook Kim Hae Lim Lee Hee Yeon Kim Sung Won Lee Ahlim Lee U Im Chang Do Seon Song Seok-Hwan Kim Myeong Jun Song Pil Soo Sung Jong Young Choi Seung Kew Y Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Learning | Liver | Liver Cancer | Study | Training | Universities & Medical Training | Urology & Nephrology